Xenon Pharmaceuticals Inc.
XENEDrugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
5
Next Catalyst
Aug 10, 2026
13dMarket Overview
Stock performance and key metrics
5 upcoming, 0 past
XENE Earnings Report
EPS Est: $-1.16 | FQ end 2026-06
4 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How XENE's past catalysts played out
XEN1101
Primary Generalized Tonic-Clonic Seizures
Azetukalner
Major Depressive Disorder
XEN1101 10 mg
Major Depressive Disorder
XPF-005
Acne Vulgaris
XPF-001
Dental Pain
XPF-002
Postherpetic Neuralgia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
XEN1101 | Phase 3 | Primary Generalized Tonic-Clonic Seizures | - | - |
Azetukalner | Phase 3 | Major Depressive Disorder | - | - |
XEN1101 10 mg | Phase 2 | Major Depressive Disorder | - | - |
XPF-005 | Phase 2 | Acne Vulgaris | - | - |
XPF-001 | Phase 2 | Dental Pain | - | - |
XPF-002 | Phase 2 | Postherpetic Neuralgia | - | - |
Major Depressive Disorder
2 drugs in this indication
Acne Vulgaris
1 drug in this indication
Postherpetic Neuralgia
1 drug in this indication
Primary Generalized Tonic-Clonic Seizures
1 drug in this indication
Dental Pain
1 drug in this indication
Focal Onset Seizures
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Xenon Pharmaceuticals Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Xenon Pharmaceuticals Inc.'s (XENE) pipeline across Phase 3, Phase 2. Its lead program is XEN1101 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Xenon Pharmaceuticals Inc.'s next FDA catalyst?→
Xenon Pharmaceuticals Inc.'s (XENE) next tracked catalyst is a Earnings expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track XENE biotech catalysts?→
Add XENE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Xenon Pharmaceuticals Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.